[Expression of Concern] Anti‑metastatic and differential effects on protein expression of epigallocatechin‑3‑gallate in HCCLM6 hepatocellular carcinoma cells.
- 1Department of Biotechnology, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.
- 2School of Medicine, Deakin University, Victoria, Australia.
Abstract
Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, for the cell invasion assay experiments shown in Fig. 2A on p. 962, panels 'b' and 'c' (showing treatment with 5 µg/ml or 10 µg/ml epigallocatechin‑3‑gallate respectively) contained an overlapping section of data, such that these data, which were intended to show the results from differently performed experiments, appeared to have been derived from the same original source. The authors have been contacted by the Editorial Office to offer an explanation for the apparently incorrect assembly of data in Fig. 2, and we are awaiting their response. Owing to the fact that the Editorial Office has been made aware of potential issues surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office conitnues to investigate this matter further. [International Journal of Molecular Medicine 32: 959‑964, 2013; DOI: 10.3892/ijmm.2013.1446].
Related
- Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling
- Differential Expression of Salivary microRNA Associated with Keratoconus
- Aberrant CPS1 expression is linked to metabolic alterations and metastatic phenotypes in colorectal cancer liver metastasis
- Endothelial protein C receptor expression as a marker of reduced metastatic risk in primary melanoma
- Aberrant Transcription-Factor Expression and Regulatory microRNAs in Metastatic Breast Cancer
BibTeX
@article{zhang2026expression,
title = {{[Expression of Concern] Anti‑metastatic and differential effects on protein expression of epigallocatechin‑3‑gallate in HCCLM6 hepatocellular carcinoma cells.}},
author = {Yunjuan Zhang and Lawrence Owusu and Wei Duan and Tao Jiang and Shizhu Zang and Ayaz Ahmed and Yi Xin},
journal = {International journal of molecular medicine},
year = {2026},
month = oct,
doi = {10.3892/ijmm.2026.6014},
url = {https://europepmc.org/article/MED/42885296},
note = {CC BY},
}
RIS
TY - JOUR
TI - [Expression of Concern] Anti‑metastatic and differential effects on protein expression of epigallocatechin‑3‑gallate in HCCLM6 hepatocellular carcinoma cells.
AU - Yunjuan Zhang
AU - Lawrence Owusu
AU - Wei Duan
AU - Tao Jiang
AU - Shizhu Zang
AU - Ayaz Ahmed
AU - Yi Xin
PY - 2026
DA - 2026/10/16
JO - International journal of molecular medicine
DO - 10.3892/ijmm.2026.6014
UR - https://europepmc.org/article/MED/42885296
AB - Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, for the cell invasion assay experiments shown in Fig. 2A on p. 962, panels 'b' and 'c' (showing treatment with 5 µg/ml or 10 µg/ml epigallocatechin‑3‑gallate respectively) contained an overlapping section of data, such that these data, which were intended to show the results from differently performed experiments, appeared to have been derived from the same original source. The authors have been contacted by the Editorial Office to offer an explanation for the apparently incorrect assembly of data in Fig. 2, and we are awaiting their response. Owing to the fact that the Editorial Office has been made aware of potential issues surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office conitnues to investigate this matter further. [International Journal of Molecular Medicine 32: 959‑964, 2013; DOI: 10.3892/ijmm.2013.1446].
SN - 1107-3756
SN - 1791-244X
ER -